CIP2A Antibody

CIP2A (cancerous inhibitor of PP2A) was originally identified as p90, a cytoplasmic autoantigen found in the serum from a cancer patient. It was later described as a protein that interacted with the c-myc oncogene and functioned as an inhibitor of protein phosphatase 2A (PP2A) activity. Inhibition of PP2A phosphatase activity by CIP2A prevents c-myc phosphorylation and counteracts c-myc proteolytic degradation, thereby stabilizing c-myc and promoting cell growth and transformation. CIP2A is found to be overexpressed in some human malignancies and is thus classified as an oncogene that may be an important contributor to tumor formation.
    Product Specifications
    Catalog # Size Price
    CIP2A AntibodyReactivity: Human
    Applications: IP, IHC-P, IF
    Immunogen: Between 550 and 600
    A301-453A100 µl (1 mg/ml) $339Add to Cart
    A301-453A-T10 µl (1 mg/ml) $50Add to Cart
    CIP2A AntibodyReactivity: Human, Mouse, Rat
    Applications: WB, IP, IHC-P, IF
    Immunogen: Between 853 and 903
    A301-454A100 µl (0.2 mg/ml) $339Add to Cart
    A301-454A-M100 µl (10 blots) $229Add to Cart
    A301-454A-T20 µl (2 blots) $50Add to Cart
    CIP2A Monoclonal AntibodyReactivity: Human
    Applications: WB, IP
    A500-010A0.1 ml (50-250 blots) $339Add to Cart
    CIP2A IHC AntibodyApplications: IHC-P, IF
    Reactivity: Human
    Immunogen: Between 550 and 600
    IHC-00266100 µl (50+ slides) $360Add to Cart
    IHC-00266-T10 µl (5+ slides) $50Add to Cart
    Applications: WB, IP, IHC-P, IF
    Reactivity: Human, Mouse, Rat
    Includes: 1 each of A301-453A and A301-454A
    A310-506A1 Pack $472Add to Cart

    Please note that Cookies and JavaScript are required for you to view this website.

    Check if you have Cookies and JavaScript enabled in your browser